You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
李氏大药厂(00950.HK):兆科眼科已向联交所递交主板上市申请
格隆汇 12-18 22:05

格隆汇 12 月 18日丨李氏大药厂(00950.HK)公布,有关可能将兆科眼科分拆及独立上市。于2020年12月18日向联交所呈交上市申请表格(A1表格),以申请批准兆科普通股以全球发售方式于联交所主板上市及买卖。

经适当及审慎考虑建议分拆,并适当考虑股东的利益后,倘进行建议分拆,则计划在兆科眼科的董事会决定进行建议分拆及全球发售,以及上市委员会批准上市等若干条件的规限下,以根据全球发售优先发售兆科普通股的方式,向合资格现有股东提供兆科普通股保证配额。有关保证配额的详情尚未落实。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account